Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 13 | 2021 | 110 | 2.040 |
Why?
|
| Subarachnoid Hemorrhage | 9 | 2021 | 40 | 1.130 |
Why?
|
| Consciousness Disorders | 1 | 2022 | 7 | 0.830 |
Why?
|
| Critical Illness | 1 | 2022 | 136 | 0.740 |
Why?
|
| Brain Diseases | 1 | 2021 | 67 | 0.720 |
Why?
|
| Hospital Mortality | 8 | 2022 | 146 | 0.680 |
Why?
|
| Fever | 1 | 2017 | 36 | 0.550 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 6 | 2021 | 96 | 0.400 |
Why?
|
| Time Factors | 11 | 2020 | 1489 | 0.370 |
Why?
|
| Humans | 32 | 2022 | 28117 | 0.350 |
Why?
|
| Drainage | 3 | 2021 | 49 | 0.350 |
Why?
|
| Brain Ischemia | 2 | 2021 | 63 | 0.340 |
Why?
|
| Stroke | 4 | 2017 | 272 | 0.330 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2019 | 114 | 0.330 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 991 | 0.320 |
Why?
|
| Female | 22 | 2021 | 15583 | 0.310 |
Why?
|
| Cerebral Infarction | 2 | 2021 | 150 | 0.290 |
Why?
|
| Brain Edema | 2 | 2020 | 18 | 0.290 |
Why?
|
| Middle Aged | 18 | 2021 | 9188 | 0.290 |
Why?
|
| Encephalocele | 2 | 2020 | 24 | 0.280 |
Why?
|
| Retrospective Studies | 11 | 2021 | 3537 | 0.280 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 30 | 0.270 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 2 | 2019 | 9 | 0.270 |
Why?
|
| Male | 22 | 2021 | 15173 | 0.270 |
Why?
|
| Risk Factors | 8 | 2021 | 2375 | 0.270 |
Why?
|
| Fibrinolytic Agents | 3 | 2017 | 56 | 0.260 |
Why?
|
| Cerebral Ventricles | 2 | 2017 | 20 | 0.250 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2017 | 40 | 0.240 |
Why?
|
| Hydrocephalus | 2 | 2021 | 20 | 0.230 |
Why?
|
| Prospective Studies | 8 | 2021 | 1763 | 0.230 |
Why?
|
| Intracranial Thrombosis | 2 | 2020 | 6 | 0.210 |
Why?
|
| Consciousness | 1 | 2022 | 4 | 0.210 |
Why?
|
| Weather | 2 | 2019 | 13 | 0.200 |
Why?
|
| Length of Stay | 3 | 2021 | 328 | 0.200 |
Why?
|
| Aged | 15 | 2021 | 9223 | 0.190 |
Why?
|
| Hospitals | 1 | 2022 | 153 | 0.190 |
Why?
|
| Pandemics | 2 | 2020 | 257 | 0.190 |
Why?
|
| Critical Care | 2 | 2020 | 195 | 0.190 |
Why?
|
| Leukocytosis | 1 | 2021 | 4 | 0.180 |
Why?
|
| Hospitalization | 2 | 2020 | 320 | 0.180 |
Why?
|
| Cerebrum | 1 | 2021 | 11 | 0.180 |
Why?
|
| Brain Death | 1 | 2020 | 9 | 0.180 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 8 | 0.180 |
Why?
|
| Neurologists | 1 | 2020 | 4 | 0.180 |
Why?
|
| Occupational Health | 1 | 2020 | 22 | 0.180 |
Why?
|
| Apnea | 1 | 2020 | 15 | 0.180 |
Why?
|
| Health Care Rationing | 1 | 2020 | 6 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2020 | 33 | 0.180 |
Why?
|
| Cerebral Angiography | 3 | 2021 | 35 | 0.170 |
Why?
|
| Logistic Models | 3 | 2017 | 397 | 0.170 |
Why?
|
| Rivaroxaban | 1 | 2020 | 5 | 0.170 |
Why?
|
| Hematoma, Subdural | 1 | 2020 | 7 | 0.170 |
Why?
|
| Hemostasis | 1 | 2020 | 10 | 0.170 |
Why?
|
| Risk Assessment | 3 | 2021 | 665 | 0.170 |
Why?
|
| Pyridones | 1 | 2020 | 11 | 0.170 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 5 | 0.170 |
Why?
|
| Hemostatics | 1 | 2020 | 13 | 0.170 |
Why?
|
| Prognosis | 3 | 2020 | 819 | 0.170 |
Why?
|
| Pregnancy | 1 | 2021 | 341 | 0.170 |
Why?
|
| Electroencephalography | 1 | 2020 | 80 | 0.170 |
Why?
|
| Blood Coagulation Factors | 1 | 2020 | 19 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2020 | 108 | 0.170 |
Why?
|
| Seizures | 1 | 2020 | 67 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 67 | 0.170 |
Why?
|
| Vasospasm, Intracranial | 1 | 2019 | 10 | 0.170 |
Why?
|
| Endocarditis | 1 | 2019 | 10 | 0.170 |
Why?
|
| Neurology | 1 | 2020 | 58 | 0.170 |
Why?
|
| Brain Injuries | 1 | 2019 | 36 | 0.160 |
Why?
|
| Pyrazoles | 1 | 2020 | 58 | 0.160 |
Why?
|
| Disease Management | 1 | 2019 | 114 | 0.160 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 120 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 196 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 321 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 91 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 95 | 0.150 |
Why?
|
| Adult | 10 | 2021 | 8036 | 0.140 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2017 | 1 | 0.140 |
Why?
|
| Body Temperature Regulation | 1 | 2017 | 21 | 0.140 |
Why?
|
| Therapeutic Irrigation | 1 | 2017 | 56 | 0.140 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 145 | 0.140 |
Why?
|
| Sodium Chloride | 1 | 2017 | 38 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2017 | 269 | 0.130 |
Why?
|
| Cytokines | 1 | 2017 | 240 | 0.130 |
Why?
|
| Chicago | 4 | 2020 | 905 | 0.120 |
Why?
|
| Thrombolytic Therapy | 2 | 2013 | 46 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2021 | 3531 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 4846 | 0.110 |
Why?
|
| Troponin I | 1 | 2013 | 12 | 0.110 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 15 | 0.100 |
Why?
|
| Community Health Centers | 1 | 2012 | 13 | 0.100 |
Why?
|
| Young Adult | 5 | 2019 | 2048 | 0.100 |
Why?
|
| Warfarin | 1 | 2012 | 26 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 492 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2012 | 90 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 5 | 0.090 |
Why?
|
| Transportation of Patients | 1 | 2011 | 4 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 1181 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 758 | 0.090 |
Why?
|
| Perfusion Imaging | 1 | 2010 | 6 | 0.090 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 13 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 18 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 35 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 243 | 0.080 |
Why?
|
| Leukocyte Count | 2 | 2021 | 67 | 0.080 |
Why?
|
| Atmospheric Pressure | 2 | 2019 | 8 | 0.080 |
Why?
|
| Brain Infarction | 1 | 2009 | 75 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2021 | 162 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 291 | 0.080 |
Why?
|
| Age Factors | 2 | 2020 | 790 | 0.070 |
Why?
|
| Incidence | 2 | 2019 | 757 | 0.070 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2017 | 9 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2020 | 298 | 0.060 |
Why?
|
| Biomarkers | 2 | 2020 | 583 | 0.060 |
Why?
|
| United States | 2 | 2020 | 2161 | 0.060 |
Why?
|
| Hypertension | 2 | 2018 | 225 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 7 | 0.050 |
Why?
|
| Weaning | 1 | 2021 | 5 | 0.050 |
Why?
|
| Brain | 2 | 2021 | 1690 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 30 | 0.050 |
Why?
|
| Patient Admission | 1 | 2021 | 26 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2020 | 57 | 0.040 |
Why?
|
| Registries | 2 | 2012 | 182 | 0.040 |
Why?
|
| Critical Care Nursing | 1 | 2020 | 11 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2020 | 23 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 22 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 19 | 0.040 |
Why?
|
| Triage | 1 | 2020 | 21 | 0.040 |
Why?
|
| Self Concept | 1 | 2020 | 42 | 0.040 |
Why?
|
| Physician Assistants | 1 | 2020 | 15 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 41 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2019 | 7 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 115 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2019 | 16 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 28 | 0.040 |
Why?
|
| Syndrome | 1 | 2019 | 81 | 0.040 |
Why?
|
| Nurses | 1 | 2020 | 55 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 138 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 57 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 77 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2021 | 290 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 511 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 154 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 67 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 318 | 0.040 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 111 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 497 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 214 | 0.040 |
Why?
|
| Physicians | 1 | 2020 | 123 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 354 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 475 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2020 | 292 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2020 | 242 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2017 | 19 | 0.040 |
Why?
|
| Leukocytes | 1 | 2017 | 38 | 0.040 |
Why?
|
| Glucose | 1 | 2017 | 62 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 715 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1368 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 344 | 0.030 |
Why?
|
| Factor VIIa | 1 | 2012 | 7 | 0.030 |
Why?
|
| Plasma | 1 | 2012 | 19 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 18 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2013 | 424 | 0.030 |
Why?
|
| Smoking | 1 | 2012 | 177 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2010 | 7 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 8 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 466 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 2291 | 0.020 |
Why?
|